United States Adopted Names

U·ni·ted States A·dopt·ed Names (USAN),

(yū-nī'tĕd stāts a-dopt'ĕd nāmz),
Designation for nonproprietary names (for drugs) adopted by the USAN Council in cooperation with the manufacturers concerned; the designation USAN is applicable only to nonproprietary names coined since June 1961.

United States Adopted Names

See USAN.

U·ni·ted States A·dopt·ed Names

(USAN) (yū-nī'tĕd stāts ă-dop'tĕd nāmz)
Designation for nonproprietary names (for drugs) adopted by the USAN Council in cooperation with the manufacturers concerned; the designation USAN is applicable only to nonproprietary names coined since June 1961.

Uni·ted States A·dopt·ed Names

(USAN) (yū-nī'tĕd stāts ă-dop'tĕd nāmz)
Designation for nonproprietary names (for drugs) adopted by the USAN Council in cooperation with the manufacturers concerned.
References in periodicals archive ?
Collaboration with the United States Adopted Names (USAN) Council and the World Health Organization's International Nonproprietary Naming (INN) program is likely to continue.
They appear in several databases such as the Veterans Administration National Drug File Reference Terminology, the USP Dictionary of United States Adopted Names (USAN) and International Drug Names (INN), and the RxNorm database.
This approval was awarded by the World Health Organisation (WHO) and the United States Adopted Names (USAN) Council.
Food and Drug Administration's Center for Biologies Evaluation and Research and the United States Adopted Names Council as the nonproprietary name for Aastrom's investigational cell therapy product.
The compound names have been adopted by the United States Adopted Names (USAN) Council and the World Health Organization (WHO).
This 40th edition of the USP Dictionary lists new United States Adopted Names (USAN), among other updated listings.
The United States Adopted Names (USAN) Council and the World Health Organization (WHO) have approved the generic name bremelanotide for PT-141, the first in a new class of experimental treatments for sexual dysfunction.
The generic name "sipuleucel-T" has been approved by the United States Adopted Names (USAN) Council for Dendreon's investigational active cellular immunotherapy (ACI) for prostate cancer, previously known as APC8015.
He also serves as secretary to the United States Adopted Names Review Board.

Full browser ?